Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.51 |
| ▸ | NPY1R | P25929 | 6/20 | 0.51 |
| ▸ | NPY2R | P49146 | 5/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.51 |
| ▸ | REN | P00797 | 2/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
| ▸ | CTSK | P43235 | 1/20 | 0.45 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.44 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.44 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.44 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.44 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.44 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.44 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.44 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.44 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29550188 | 0.92 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RREN | |
| SCHEMBL30202260 | 0.91 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5RREN | |
| SCHEMBL31272846 | 0.91 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31669623 | 0.86 | MEN1 (0.51) | NPY4RNPY1RNPY2RNPY5RCTSL | |
| SCHEMBL23352495 | 0.85 | REN (0.56) | NPY4RNPY1RNPY2RNPY5RREN | |
| SCHEMBL13956678 | 0.84 | PAX8 (0.52) | NPY4RNPY1RCTSLCTSKPSMB8 | |
| SCHEMBL31326043 | 0.84 | ITGB3 (0.58) | ITGB3ITGA2BCTSLCTSKPSMB8 | |
| SCHEMBL3387924 | 0.83 | PAX8 (0.53) | ITGB3ITGA2BCTSLCTSK | |
| SCHEMBL21981319 | 0.83 | REN (0.53) | NPY4RNPY1RRENPSEN1PSEN2 | |
| SCHEMBL21981320 | 0.83 | REN (0.53) | NPY4RNPY1RRENPSEN1PSEN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11566058-B2 | Process for the preparation of high purity glucagon | Fresenius Kabl iPSUM S.R.L. (IT) | 2023-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11566058-B2 | Process for the preparation of high purity glucagon | IAPP, GCG, GLP1R | NPY4R 7/4885NPY1R 22/4885NPY2R 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.